Interestingly, class G0 MAb 77D2, G1 MAb 40D8, 1D9 and 36E10 as well as G2 MAb 7G6 treated animals showed lower pathology than 131-2G treated animals following RSV-A2 challenge, although these differences did not reach statistical significance (Fig. 2c ).
← all excerpts
Monoclonal antibodies targeting sites in respiratory syncytial virus attachment G protein provide protection against RSV-A and RSV-B in mice.
1
—
—